Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD) (NCT05329649)
OrganizationBiotech
Vertex Pharmaceuticals Incorporated
Organization linked by public source evidence.
Public IDs
No public external ID is attached.
Related people
No reviewed person affiliation is attached.
Outputs
No reviewed output is linked through affiliated people.
Topics
Relationship evidence
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT) (NCT05356195)
Timeline
No dated relationship evidence is attached.